Bli medlem
Bli medlem

Du är här

2019-05-14

Q-linea: Redeye initiates coverage of Q-linea

Q-linea is about 12 months from launching ASTar - a diagnostic system
for rapid phenotypic antibiotic susceptibility testing (AST). The
share's underperformance indicates that investors have yet to grasp
the technology's paradigm-shifting impact and the product portfolio's
high sales potential.

Read more and download the research update: http://bit.ly/2VAuTkp

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment
Banking. https://www.redeye.se/about/

-----------------------------------------------------------
https://news.cision.com/se/q-linea/r/redeye-initiates-coverage-of-q-line...

Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.